The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients
We demonstrate evidence supporting the efficacy of hydroxocobalamin in reducing vasopressor requirements for LVAD patients with refractory vasoplegia. Further study is needed to substantiate these findings and determine its optimal use in practice. AbstractWe demonstrate evidence supporting the efficacy of hydroxocobalamin in reducing vasopressor requirements for LVAD patients with refractory vasoplegia. Further study is needed to substantiate these findings and determine its optimal use in practice.
Source: Clinical Case Reports - Category: General Medicine Authors: Brian Ayers,
Katherine Wood,
Jennifer Falvey,
Wendy Bernstein,
Igor Gosev Tags: CASE REPORT Source Type: research